Metraipolis › archive › dc_5c575fbc071b

Design and in silico evaluation of an mRNA vaccine against HTLV-1 using AI-driven reverse vaccinology approaches — Europe PMC PMID:42090365

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42090365
DOI
10.1371/journal.pone.0340201
License (as archived)
solo-consultazione
Archived
2026-11-02T15:38:19.931Z
SHA-256 of the archived text
e88c97ca259c3546c66062a9b083b79a03ba35554d93781f24787b3316c151ab
Stable URL of this page
https://metraipolis.com/documento/dc_5c575fbc071b

How to cite

Design and in silico evaluation of an mRNA vaccine against HTLV-1 using AI-driven reverse vaccinology approaches — Europe PMC PMID:42090365 — Europe PMC (en), https://europepmc.org/article/MED/42090365 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5c575fbc071b (Metraipolis archive dc_5c575fbc071b, sha256 e88c97ca259c3546c66062a9b083b79a03ba35554d93781f24787b3316c151ab)
BibTeX
@misc{dc5c575fbc071b,
  title = {Design and in silico evaluation of an mRNA vaccine against HTLV-1 using AI-driven reverse vaccinology approaches — Europe PMC PMID:42090365},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42090365},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5c575fbc071b; sha256 e88c97ca259c3546c66062a9b083b79a03ba35554d93781f24787b3316c151ab},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42090365. Agents can read the archived copy with the MCP tool read_document.